Global Spirometer Device Market Overview:
A spirometer device is an instrument used to measure the air capacity of the lungs. It measures the volume of air expired by the lungs and entering the apparatus. Spirometer device is used to monitor various respiratory diseases such as asthma, emphysema, and bronchitis, among others. Moreover, an incentive spirometer device can be used after the surgery, in order to keep the respiratory system healthy. It is used by patients recovering from cardiac surgeries and other related illnesses. Some of the key players profiled in the study are Hill-Rom (United States), Vyaire Medical (United States), Fukuda Sangyo (Japan), Chest MI (Japan), Schiller AG (Switzerland), MGC Diagnostics (United States), Medical International Research (Italy), NDD Medical Technologies (Switzerland), Vitalograph (United Kingdom) and MidMark Corporation (United States).
On the basis of geography, the market of Spirometer Device has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Offline will boost the Spirometer Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Spirometer Device market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Rising geriatric population is increasing the adoption of home-based spirometer for the monitoring of chronic respiratory diseases, in turn, fueling the growth of the global spirometer market. Along with this there is rising incidences of respiratory diseases
- Introduction of advanced technology like integration of cell phones with spirometers
- Lack of awareness among the population regarding the prevalence of various pulmonary respiratory devices
- Urbanization has increased the level of population, leading to the prevalence of respiratory diseases in the developed economies
- Need for skilled professionals and the possibility of inaccuracy
- Time required to perform the test
In 2018, Schiller AG launched the CARDIOVIT CS-200 Office ErgoSpiro system. The CARDIOVIT CS-200 Excellence ErgoSpiro system performs both pulmonary function tests and metabolic tests with diagnostic-quality 12- or 16-lead exercise ECG conveniently and accurately in a single device.
Despite the presence of competition and brand effect problems, due to the awareness of end-users and their demand for high end products, investors are still optimistic about this area. There will be more new investors entering into this industry in the future. The manufacturers who want to occupy the market must depend on market mechanism reform, manufacturing equipment innovation, core technology improvement and brand establishment.
Target Audience:Industry Investors, Manufacturers, End User Industries, Hospitals, Clinics, and Laboratories, Traders, Distributors, and Suppliers, Government and Research Organizations, Associations and Industry Bodies and Others
Major Objectives Focused through this Study To define, describe, and forecast the Global Spirometer Device market on the basis of product [PC-based, Portable and Table-top] , application [COPD, Asthma and Other Applications], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Spirometer Device market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Spirometer Device industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Ambisea Technology, ANA-MED, Besmed Health Business, Bionet, BTL International, Cardioline and Clarity Medical.
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Spirometer Device market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.